Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Secondary prevention

Citations 411-420 of 568 total displayed.

Past content (since Feb 1999):

Clinical Cardiology: New Frontiers
Principles From Clinical Trials Relevant to Clinical Practice: Part II
Robert M. Califf and David L. DeMets
Circulation 2002;106:1172-1175, doi:10.1161/01.CIR.0000023218.39412.32 [Full text]  

Articles
Simvastatin Lowers C-Reactive Protein Within 14 Days. An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction
Julie K. Plenge, Teri L. Hernandez, Kathleen M. Weil, Paul Poirier, Gary K. Grunwald, Santica M. Marcovina, and Robert H. Eckel
Circulation published August 26, 2002, doi:10.1161/01.CIR.0000029743.68247.31 [Abstract]  

Clinical Cardiology: New Frontiers
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Robert M. Califf and David L. DeMets
Circulation 2002;106:1015-1021, doi:10.1161/01.CIR.0000023260.78078.BB [Full text]  

Correspondence
Primary Prevention Lipid-Lowering Drug Therapy Response
Donald O. Fedder, Carol E. Koro, Gilbert J. L’Italien, Antonio M. Gotto, Jr, and Lewis H. Kuller
Circulation 2002;106:e35-36e, doi:10.1161/01.CIR.0000025828.88749.55 [Full text]  

Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
David L. DeMets and Robert M. Califf
Circulation 2002;106:880-886, doi:10.1161/01.CIR.0000023220.26465.89 [Full text]  

Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation 2002;106:666-671; published online before print as doi:10.1161/01.CIR.0000024413.15949.ED [Abstract] [Full text]  

Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part I
David L. DeMets and Robert M. Califf
Circulation 2002;106:746-751, doi:10.1161/01.CIR.0000023219.51483.66 [Full text]  

Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II
Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:626-630, doi:10.1161/01.CIR.0000021408.40925.63 [Full text]  

Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:516-520, doi:10.1161/01.CIR.0000021407.93752.7B [Full text]  

Clinical Investigations and Reports
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation
Terence Kavanagh, Donald J. Mertens, Larry F. Hamm, Joseph Beyene, Johanna Kennedy, Paul Corey, and Roy J. Shephard
Circulation published July 22, 2002, doi:10.1161/01.CIR.0000024413.15949.ED [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

* Subspecialty Collections Home

* Show  Secondary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment